EUDA控股公司和广东细胞生物技术公司讨论了在东南亚扩大干细胞疗法的合资企业。 EUDA Holdings and Guangdong Cell Biotech discuss joint venture to expand stem cell therapies in Southeast Asia.

EUDA控股公司是新加坡的一家保健技术公司,正在与中国一家干细胞治疗公司广东细胞生物科技公司谈判组建合资企业。 EUDA Holdings, a Singapore health tech company, is in talks with Guangdong Cell Biotech, a Chinese stem cell therapy firm, to form a joint venture. 该伙伴关系旨在将欧洲开发协会的数字保健平台与广东的干细胞专业知识结合起来,以扩大东南亚各地的再生疗法。 The partnership aims to combine EUDA's digital healthcare platform with Guangdong's stem cell expertise to expand regenerative therapies across Southeast Asia. 这种合作可以加强生物技术和消费者保健部门的市场影响和创新。 This collaboration could enhance market reach and innovation in biotechnology and consumer health sectors.